The FDA Is Replacing Synthetic Food Dyes, and These 3 Just Got the Green Light
This move follows Health Secretary Robert Kennedy Jr.'s April announcement to phase out synthetic dyes like Red 40 and Yellow 5, with a national standard and timeline coming soon.
Industry leaders warn the transition may lead to higher food prices and limited product availability due to the complexity and cost of reformulating with natural colors.In late April, Robert Kennedy Jr., the Secretary of the U.S. Department of Health and Human Services, announced plans to phase out petroleum-based artificial colors from the nation's food supply. That includes Red 3 and 40, Blue 1 and 2, Yellow 5 and 6, and Green 3, all of which are used in thousands of products found on grocery store shelves.
Though Kennedy didn't provide extensive details on how his department plans to completely phase out dyes, a press release from his department stated that the Food and Drug Administration (FDA) will establish a "national standard and timeline for the food industry to transition from petrochemical-based dyes to natural alternatives." And now, it seems it's making good on at least part of that promise.
On May 9, the FDA issued a release stating it had approved three new color additive petitions to "expand the palette of available colors from natural sources" that manufacturers can use.'Today we take a major step to Make America Healthy Again,' Kennedy shared in the release. "For too long, our food system has relied on synthetic, petroleum-based dyes that offer no nutritional value and pose unnecessary health risks. We're removing these dyes and approving safe, natural alternatives—to protect families and support healthier choices.'
Martin A. Makary, the commissioner of the FDA, added that his staff has been "moving quickly to expedite the publication of these decisions, underscoring our serious intent to transition away from petroleum-based dyes in the food supply and provide new colors from natural sources.'
Specifically, the FDA approved the use of galdieria extract blue, a blue color derived from the "unicellular red algae Galdieria sulphuraria." It is now approved for use in a wide range of products, including nonalcoholic beverages, beverage bases like fruit drinks and smoothies, breakfast cereal coatings, hard candy, flavored frostings, ice cream, yogurt, and liquid creamers.
Related: Are Natural Food Dyes Better? Experts Weigh In on the Pros and Cons
Then there's butterfly pea flower extract, another blue color that can be used to "achieve a range of shades including bright blues, intense purple, and natural greens," the statement shared. The FDA noted that it's already approved for use in products such as sports drinks, alcoholic beverages, dairy drinks, and ready-to-drink teas, but now it can also be used in ready-to-eat cereals, crackers, snack mixes, hard pretzels, and chips.
Finally, the FDA approved calcium phosphate, which is a white compound that can now be used in ready-to-eat chicken products, white candy melts, doughnut sugar, and sugar for coated candies.Galdieria Extract (Blue): A bright blue dye derived from Galdieria sulphuraria, a unicellular red algae. The FDA has approved it for use in a wide range of products, including nonalcoholic beverages, cereals, hard candy, frostings, ice cream, yogurt, and creamers.
Butterfly Pea Flower Extract (Blue to Purple): A natural colorant extracted from the butterfly pea flower that produces a deep blue hue. It is pH-sensitive, turning purple or pink in acidic environments, which allows it to create a range of shades depending on the food or drink it's used in. The FDA expanded its approved uses to include snacks like chips, crackers, pretzels, and cereals.
Calcium Phosphate (White): A naturally occurring mineral used to create a white color in food products. The FDA approved it for use in ready-to-eat chicken products, doughnut sugar, sugar for coated candies, and white candy melts.The announcement noted that "once the FDA approves a color additive petition, any manufacturer can use the coloring for the approved uses," which means you could see butterfly pea flower in your favorite candy one day. However, "one day" is the key term. As the International Association of Color Manufacturers said in a statement in April following Kennedy's announcement, the process of switching color formulations is "neither simple nor immediate, and the resulting supply disruptions will limit access to familiar, affordable grocery items."
Furthermore, Amy Agallar, vice president of investor relations and treasurer at Sensient, shared with CNN that all of your favorite, colorful treats could get more expensive as a result of these decisions.
'Natural colors can be more expensive from a cost-in-use perspective depending on the raw ingredient being used," Agallar said. 'The raw ingredients can vary due to many factors such as availability, time to harvest, and color availability from the raw material. The natural color needed to replace a synthetic color can be ten times that of a synthetic product.'
Read the original article on Food & Wine
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal
We recently compiled a list of Regeneron Pharmaceuticals, Inc. tops our list for being one of the most undervalued healthcare stocks. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the most undervalued stocks. It is a leading American biotech company specializing in treatments for serious diseases across ophthalmology, immunology, oncology, and rare conditions. The company is known for integrating genetics and technology into its drug discovery efforts and continues to grow through internal innovation and strategic acquisitions. In a major move, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is acquiring most of 23andMe's assets for $256 million, including its personal genome service, research services, biobank, and associated data. This will expand the business's access to genetic information from 15 million individuals (with 80% consenting to research use), enhancing its existing warehouse of 3 million anonymized samples. The acquisition significantly boosts Regeneron's capabilities in genetics-guided drug development and precision medicine. The vast dataset will help identify new drug targets, refine clinical trial designs, and improve patient stratification. This positions the corporation to lead the integration of real-world genomic data into personalized healthcare. A pharmacist at work in their online pharmacy checking over orders for pharmaceutical products. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) continues to advance its pipeline with FDA priority reviews for Dupixent (bullous pemphigoid) and Linvoseltamab (multiple myeloma), as well as promising late-stage results for EYLEA HD in eye disorders. The firm's focus remains on leveraging data and science to drive innovative, effective therapies. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Politico
4 hours ago
- Politico
FDA head Marty Makary on food dyes, ultra-processed foods and the MAHA agenda
FDA head Marty Makary on food dyes, ultra-processed foods and the MAHA agenda | The Conversation lead image

Miami Herald
10 hours ago
- Miami Herald
Massive sleep study reveals surprising cost of going to bed late
As an avid Oura user, I'm no stranger to *slightly* obsessing over sleep data. I've tracked my deep sleep, REM cycles, HRV, and recovery scores like a mini scientist in a silk sleep mask. I've timed workouts based on my readiness score. When it comes to the link between sleep and performance, I'm not new here. But even with all that tracking and optimization, this new study got my attention. Researchers looked at millions of nights of sleep-over 6 million to be exact-and what they found was something most of us (myself included) tend to overlook. It's not just about how much you sleep. Related: FDA eliminates 52 food standards in sweeping deregulation move It's about when. And more specifically: what happens when you go to bed later than usual. The impact? Subtle at first. But if you're trying to be consistent with your workouts, boost your energy, or just feel better, those late nights might be holding you back. Even if you're still getting 7 to 8 hours of sleep. That's what makes this study different. Because this time, we're not just talking about sleep duration. We're talking about timing-and how it can affect your body and behavior the very next day. The study, published in PNAS, looked at over 6 million nights of sleep data from nearly 26,000 adults using wearable fitness trackers. Specifically, over 19,000 WHOOP users and nearly 6,000 Fitbit device users. Here's what they found: people who went to bed earlier were more likely to exercise the next day. And the difference? Bigger than you'd think. For example, compared to those who went to sleep around 1 a.m., people who consistently went to bed at 9 p.m. logged 28 more minutes of moderate-to-vigorous physical activity (MVPA) the next day. Even more surprising? People who slept less overall, but went to bed earlier, often exercised more than those who slept longer but went to bed later. In other words, timing beat out total sleep when it came to getting people moving. I spoke with Dr. Mark Czeisler, Resident Physician at Brigham and Women's Hospital and Clinical Fellow at Harvard Medical School, who co-authored the study led by Josh Leota, a Research Fellow at Monash University. Related: These clean food brands are rightfully challenging the FDA He explained why bedtime and not just sleep time matters: "People got the most intense exercise when they preserved their usual sleep amount, but went to bed earlier than they typically do," he said. "That suggests these health behaviors aren't competing with each other. They're best thought of as working in concert." Think about it: if you're staying up late to finish one more episode or scroll TikTok, you could be trading away the energy and motivation you'll need tomorrow. Dr. Czeisler also noted that early sleepers are more likely to get in their workouts before the day gets busy. Morning routines tend to be more reliable-and that consistency matters. While this study tracked people living their normal lives-not under lab conditions-it's truly a big moment for sleep and fitness tech. And it supports something companies like WHOOP, Fitbit, Apple Watch and Oura have been saying for years: when you sleep matters just as much as how much you sleep. The WHOOP data came from users who were already pretty active-averaging 90 minutes of MVPA daily. But the researchers confirmed the same trend in a broader group, using Fitbit data from the NIH's All of Us program. Even people who weren't exercising much still saw a difference. Earlier bedtimes meant more movement the next day. As Dr. Czeisler put it: "The way to guarantee exercise is really to protect the morning. And so going to bed earlier, you know, lends itself to doing that." So if you're trying to get consistent with your workouts, improve your energy, or just build better habits, maybe start by looking at the clock. Going to bed a little earlier might be the simplest, most powerful performance tool you're not using yet. Protect your mornings, people! I know I do... Related: Watch out Fitbit and Apple Watch, Amazon has entered the chat The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.